Immunogenicity and Immunologic Memory after Hepatitis B Virus Booster Vaccination in HIV‐Infected Children Receiving Highly Active Antiretroviral Therapy
Author(s) -
Mark J. Abzug,
Meredith G. Warshaw,
Howard M. Rosenblatt,
Myron J. Levin,
Sharon Nachman,
Stephen I. Pelton,
William Borkowsky,
Terence Fenton
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/605448
Subject(s) - medicine , vaccination , immunology , hepatitis b virus , immunogenicity , booster dose , population , virology , hepatitis b , hbsag , antibody , virus , immunization , environmental health
Hepatitis B virus (HBV) is an important cause of comorbidity in human immunodeficiency virus (HIV)-infected individuals. The immunogenicity of HBV vaccination in children receiving highly active antiretroviral therapy (HAART) was investigated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom